CHRISTOPHER TUNDO: Open Payments
NPI 1316432172 · SILVER SPRING, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,028 in 88 payments from 11 companies in 2025. Trend: 2023 $291 · 2024 $996 · 2025 $2,028
Food & beverage: $2,019Education: $9
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 15 | $353 |
| ABBVIE INC. | 15 | $323 |
| Alkermes, Inc. | 11 | $284 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $251 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $246 |
| Otsuka America Pharmaceutical, Inc. | 6 | $174 |
| Vanda Pharmaceuticals Inc. | 7 | $152 |
| Axsome Therapeutics, Inc. | 3 | $71 |
| Corium, LLC | 3 | $63 |
| E.R. Squibb & Sons, L.L.C. | 3 | $61 |
Products named: REXULTI, VRAYLAR, ARISTADA, CAPLYTA, TRINTELLIX, FANAPT, Auvelity, Azstarys.
Industry payments across MD — which companies pay providers there.
